Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use HYCAMTIN CAPSULES safely and effectively. See full prescribing information for HYCAMTIN CAPSULES. HYCAMTIN® (topotecan) capsules, for oral useInitial U.S. Approval: 1996
Medication labelWhy this: Advisory · dailymed-prescription
HYCAMTIN® capsules are indicated for the treatment of relapsed small cell lung cancer (SCLC) in patients with a prior complete or partial response and who are at least 45 days from the end of first-line chemotherapy.
- generic_name
- topotecan
- product_names
- topotecan
- ndc
- 66758-101, 66758-101-11, 66758-102, 66758-102-11
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en